Legal Representation
Attorney
Brian D Gildea
USPTO Deadlines
Next Deadline
172 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
April 29, 2026
Extension Available
Until April 29, 2026
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 16, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 16, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 16, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 29, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 7, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 7, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 7, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 7, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 7, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 31, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 31, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities.
Class 042
biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields.; Scientific research and development
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTHERAPEUTICS"